Clinical Trial Update: Ca-hydroxyapatite, Fluoroapatite, and Mg-Zn-hydroxyapatite for Dentin Hypersensitivity Management [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Ca-hydroxyapatite, fluoroapatite, and Mg-Zn-hydroxyapatite for dentin hypersensitivity management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Ca-hydroxyapatite (calcium hydroxyapatite)
• Fluoroapatite (fluoroapatite)
• Mg-Zn-hydroxyapatite (magnesium-zinc hydroxyapatite)

Snippet

Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: Dentin Hypersensitivity | Phase 4 | Status: COMPLETED